Physician awareness of immune-related adverse events from checkpoint inhibitors.

Authors

null

Ahmed Bilal Khalid

Indiana University School of Medicine, Indianapolis, IN

Ahmed Bilal Khalid , Shadia Ibrahim Jalal , Greg Andrew Durm

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Quality Improvement

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6571)

DOI

10.1200/JCO.2022.40.16_suppl.6571

Abstract #

6571

Poster Bd #

354

Abstract Disclosures

Similar Posters

Poster

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Real-world characterization of patients with cancer admitted with immune-related adverse events (irAEs).

Real-world characterization of patients with cancer admitted with immune-related adverse events (irAEs).

First Author: Lawson Eng

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Myasthenia gravis and Guillain-Barré syndrome adverse events with immune checkpoint inhibitors.

Myasthenia gravis and Guillain-Barré syndrome adverse events with immune checkpoint inhibitors.

First Author: Catherine R. Garcia

First Author: Yukiko Shimoda Igawa